NCT07022626

Brief Summary

A large number of patients with symptomatic ischaemic heart disease undergo coronary artery bypass grafting (CABG) to alleviate their symptoms and improve prognosis. Given the progressive nature of coronary disease, bypass grafts can narrow or block over time, leading to chest pain and the need for further invasive coronary angiography. Invasive coronary procedures in patients with bypass grafts can be more complicated due to the variation in bypass graft ostia. This can lead to longer procedure times, with higher doses of contrast and radiation and more discomfort for the patient. The aim of this study is to see if the use of computed tomography coronary angiography (CTCA) in patients with previous bypass grafts prior to invasive coronary angiography will help make their procedure safer and quicker.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
688

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 14, 2018

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

June 15, 2025

Completed
Last Updated

June 15, 2025

Status Verified

June 1, 2025

Enrollment Period

5.3 years

First QC Date

November 4, 2024

Last Update Submit

June 6, 2025

Conditions

Keywords

Coronary Artery Bypass GraftsComputed Tomography Coronary AngiographyInvasive Coronary Angiogram

Outcome Measures

Primary Outcomes (3)

  • Procedural duration

    To measure the length of coronary angiographic procedure

    timer started after the insertion of the arterial catheter and stopped when the catheters are removed

  • Incidence of Contrast Induced Nephropathy

    Defined by Kidney Disease: Improving Global Outcomes (KDIGO) criteria

    48-72 hours

  • Patient Satisfaction

    Patient satisfaction measured by validated questionnaire

    4-6 hours post angiogram +/- percutaneous coronary intervention

Secondary Outcomes (8)

  • Contrast Amount

    During procedure

  • Radiation Exposure

    During procedure

  • Angiography Related Complications

    During procedure

  • Radial Access Rate

    During procedure

  • Catheters Used

    During procedure

  • +3 more secondary outcomes

Study Arms (2)

CTCA + ICA

ACTIVE COMPARATOR

Computed Tomography Cardiac Angiography (CTCA) performed prior to invasive coronary angiography (ICA).

Procedure: CTCA

ICA only

NO INTERVENTION

Invasive coronary angiography (ICA) performed only.

Interventions

CTCAPROCEDURE

Computed Tomography Coronary Angiography (CTCA) performed prior to invasive coronary angiography (ICA)

Also known as: Computed Tomography Coronary Angiogram
CTCA + ICA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing coronary angiography +/-Percutaneous coronary Intervention
  • Previous Coronary Artery Bypass Grafting (CABG)
  • Aged ≥18
  • Patients able and willing to give their written informed consent.

You may not qualify if:

  • Subjects presenting with ST elevation myocardial infarction, cardiogenic shock (systolic blood pressure \<80 mmHg for \>30 minutes, or requiring inotropes or emergency intra aortic balloon pump for hypotension treatment) or cardiopulmonary resuscitation.
  • Subjects with eGFR \<20ml/min or on renal replacement therapy.
  • Current life-threatening condition other than vascular disease that may prevent a subject completing the study.
  • Clinical instability including cardiogenic shock, hypotension (low blood pressure-systolic blood pressure less than 90 mmHg), sustained ventricular or atrial arrhythmia requiring intravenous medications.
  • Inability to tolerate beta-blockers, including those with chronic obstructive pulmonary disease or asthma, complete heart block, second-degree atrioventricular block
  • Known contrast dye allergy.
  • Pregnancy or unknown pregnancy status.
  • Patients considered unsuitable to participate by the research team (e.g., due to medical reasons, laboratory abnormalities, or subject's unwillingness to comply with all study related procedures).
  • Inability or refusal to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Royal London Hospital

London, E1 1FR, United Kingdom

Location

St Bartholomew's Hospital

London, United Kingdom

Location

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Daniel Jones, MRCP, PhD

    Queen Mary University of London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

June 15, 2025

Study Start

November 14, 2018

Primary Completion

February 28, 2024

Study Completion

February 28, 2024

Last Updated

June 15, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

The trial protocol will be published

Shared Documents
STUDY PROTOCOL
Time Frame
Mid-late 2018
Access Criteria
Freely available via journal

Locations